Detalhe da pesquisa
1.
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Br J Haematol
; 201(2): 267-279, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541152
2.
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.
Br J Haematol
; 201(4): 682-689, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822820
3.
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
PLoS Med
; 18(1): e1003454, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428632
4.
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.
Br J Haematol
; 192(5): 853-868, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656799
5.
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
Haematologica
; 106(7): 1957-1967, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499244
6.
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(1): 57-73, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559051
7.
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival.
Br J Haematol
; 185(1): 89-92, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30637732
8.
A rare presentation of a rare disease: cold haemagglutination disease as the first manifestation of IgM myeloma.
Br J Haematol
; 197(6): 649, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35312064
9.
Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation.
Ann Hematol
; 101(11): 2553-2554, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907039
10.
Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.
Eur J Haematol
; 99(4): 300-305, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632322
11.
COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium.
Br J Haematol
; 192(1): e11-e14, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151540
12.
COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.
Br J Haematol
; 190(2): e67-e70, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469077
13.
Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial).
Br J Haematol
; 185(3): 573-578, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30125960
14.
Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting.
Clin Lymphoma Myeloma Leuk
; 24(2): e40-e49.e3, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996265
15.
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis.
Amyloid
; 30(3): 290-296, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216268
16.
Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies.
Haematologica
; 102(8): e293-e296, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495916
17.
Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort.
PLoS One
; 17(7): e0270854, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797277
18.
Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial.
BMJ Open
; 12(6): e056147, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654466
19.
Current opinions and controversies in chronic myeloid leukaemia.
Curr Opin Oncol
; 23(6): 659-64, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21918441
20.
Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients.
Anticancer Res
; 41(8): 4017-4020, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34281867